Principal Street Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Principal Street Partners's AMGN Position: Q2 2026 in Review
Principal Street Partners reduced its Amgen (AMGN) stake by 0.92% in Q2 2026, selling an estimated $64.4K and leaving 20,308 shares worth $7.35M. The position accounts for 1.08% of the portfolio, ranked #28.
Principal Street Partners first reported a position in AMGN in Q3 2019 and has held it in 28 quarters since. The position peaked at $13.3M in Q1 2021. 3,158 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Principal Street Partners held 20,308 shares of Amgen worth $7.35M as of Q2 2026.
- Principal Street Partners sold 188 Amgen shares in Q2 2026, an estimated $64.4K.
- Amgen made up 1.08% of Principal Street Partners's portfolio in Q2 2026, its #28 holding.
- Principal Street Partners first reported a position in Amgen in Q3 2019 and has held it in 28 quarters since.
- Principal Street Partners's Amgen position peaked at $13.3M in Q1 2021.
- 3,158 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Principal Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.